We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Files EUA Submission for Monoclonal Antibody, Citing Positive Results
Eli Lilly Files EUA Submission for Monoclonal Antibody, Citing Positive Results
Eli Lilly has submitted a request for an Emergency Use Authorization (EUA) for its monoclonal antibody LY-CoV555, following new positive trial data for its antibody combo in treating COVID-19.